Bortezomib-Based Graft-Versus-Host Disease Prophylaxis in HLA-Mismatched Unrelated Donor Transplantation

PURPOSE: HLA-mismatched unrelated donor (MMUD) hematopoietic stem-cell transplantation (HSCT) is associated with increased graft-versus-host disease (GVHD) and impaired survival. In reduced-intensity conditioning (RIC), neither ex vivo nor in vivo T-cell depletion (eg, antithymocyte globulin) convin...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Koreth, John, Stevenson, Kristen E., Kim, Haesook T., McDonough, Sean M., Bindra, Bhavjot, Armand, Philippe, Ho, Vincent T., Cutler, Corey, Blazar, Bruce R., Antin, Joseph H., Soiffer, Robert J., Ritz, Jerome, Alyea, Edwin P.
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Clinical Oncology 2012
Assuntos:
Original Reports
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3434979/
https://ncbi.nlm.nih.gov/pubmed/22869883
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2012.42.0984
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares